 | • レポートコード：MRC2-11QY00245 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、112ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はコレステロール薬のグローバル市場について調査・分析したレポートです。種類別（経口、注射）市場規模、用途別（心血管疾患、肝疾患、心臓病、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別コレステロール薬の競争状況、市場シェア ・世界のコレステロール薬市場：種類別市場規模 2015年-2020年（経口、注射） ・世界のコレステロール薬市場：種類別市場規模予測 2021年-2026年（経口、注射） ・世界のコレステロール薬市場：用途別市場規模 2015年-2020年（心血管疾患、肝疾患、心臓病、その他） ・世界のコレステロール薬市場：用途別市場規模予測 2021年-2026年（心血管疾患、肝疾患、心臓病、その他） ・北米のコレステロール薬市場分析：米国、カナダ ・ヨーロッパのコレステロール薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのコレステロール薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のコレステロール薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのコレステロール薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Pfizer Inc、Eli Lilly and Company、Abbott Laboratories、Merck & Co、Bristol-Myers Squibb Company、AstraZeneca、Amgen Inc、Novartis AG、GlaxoSmithKline、Regeneron Pharmaceuticals ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Cholesterol Medicines Market
The global Cholesterol Medicines market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Cholesterol Medicines Scope and Market Size
Cholesterol Medicines market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Cholesterol Medicines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Cholesterol Medicines market is segmented into
Oral
Injection
Segment by Application, the Cholesterol Medicines market is segmented into
Cardiovascular Diseases
Liver Disease
Heart Disease
Others
Regional and Country-level Analysis
The Cholesterol Medicines market is analysed and market size information is provided by regions (countries).
The key regions covered in the Cholesterol Medicines market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Cholesterol Medicines Market Share Analysis
Cholesterol Medicines market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Cholesterol Medicines business, the date to enter into the Cholesterol Medicines market, Cholesterol Medicines product introduction, recent developments, etc.
The major vendors covered:
Pfizer Inc
Eli Lilly and Company
Abbott Laboratories
Merck & Co
Bristol-Myers Squibb Company
AstraZeneca
Amgen Inc
Novartis AG
GlaxoSmithKline
Regeneron Pharmaceuticals
1 Study Coverage
1.1 Cholesterol Medicines Product Introduction
1.2 Market Segments
1.3 Key Cholesterol Medicines Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Cholesterol Medicines Market Size Growth Rate by Type
1.4.2 Oral
1.4.3 Injection
1.5 Market by Application
1.5.1 Global Cholesterol Medicines Market Size Growth Rate by Application
1.5.2 Cardiovascular Diseases
1.5.3 Liver Disease
1.5.4 Heart Disease
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Cholesterol Medicines Market Size, Estimates and Forecasts
2.1.1 Global Cholesterol Medicines Revenue 2015-2026
2.1.2 Global Cholesterol Medicines Sales 2015-2026
2.2 Global Cholesterol Medicines, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Cholesterol Medicines Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Cholesterol Medicines Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Cholesterol Medicines Competitor Landscape by Players
3.1 Cholesterol Medicines Sales by Manufacturers
3.1.1 Cholesterol Medicines Sales by Manufacturers (2015-2020)
3.1.2 Cholesterol Medicines Sales Market Share by Manufacturers (2015-2020)
3.2 Cholesterol Medicines Revenue by Manufacturers
3.2.1 Cholesterol Medicines Revenue by Manufacturers (2015-2020)
3.2.2 Cholesterol Medicines Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Cholesterol Medicines Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Cholesterol Medicines Revenue in 2019
3.2.5 Global Cholesterol Medicines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Cholesterol Medicines Price by Manufacturers
3.4 Cholesterol Medicines Manufacturing Base Distribution, Product Types
3.4.1 Cholesterol Medicines Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Cholesterol Medicines Product Type
3.4.3 Date of International Manufacturers Enter into Cholesterol Medicines Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Cholesterol Medicines Market Size by Type (2015-2020)
4.1.1 Global Cholesterol Medicines Sales by Type (2015-2020)
4.1.2 Global Cholesterol Medicines Revenue by Type (2015-2020)
4.1.3 Cholesterol Medicines Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Cholesterol Medicines Market Size Forecast by Type (2021-2026)
4.2.1 Global Cholesterol Medicines Sales Forecast by Type (2021-2026)
4.2.2 Global Cholesterol Medicines Revenue Forecast by Type (2021-2026)
4.2.3 Cholesterol Medicines Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Cholesterol Medicines Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Cholesterol Medicines Market Size by Application (2015-2020)
5.1.1 Global Cholesterol Medicines Sales by Application (2015-2020)
5.1.2 Global Cholesterol Medicines Revenue by Application (2015-2020)
5.1.3 Cholesterol Medicines Price by Application (2015-2020)
5.2 Cholesterol Medicines Market Size Forecast by Application (2021-2026)
5.2.1 Global Cholesterol Medicines Sales Forecast by Application (2021-2026)
5.2.2 Global Cholesterol Medicines Revenue Forecast by Application (2021-2026)
5.2.3 Global Cholesterol Medicines Price Forecast by Application (2021-2026)
6 North America
6.1 North America Cholesterol Medicines by Country
6.1.1 North America Cholesterol Medicines Sales by Country
6.1.2 North America Cholesterol Medicines Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Cholesterol Medicines Market Facts & Figures by Type
6.3 North America Cholesterol Medicines Market Facts & Figures by Application
7 Europe
7.1 Europe Cholesterol Medicines by Country
7.1.1 Europe Cholesterol Medicines Sales by Country
7.1.2 Europe Cholesterol Medicines Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Cholesterol Medicines Market Facts & Figures by Type
7.3 Europe Cholesterol Medicines Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Cholesterol Medicines by Region
8.1.1 Asia Pacific Cholesterol Medicines Sales by Region
8.1.2 Asia Pacific Cholesterol Medicines Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Cholesterol Medicines Market Facts & Figures by Type
8.3 Asia Pacific Cholesterol Medicines Market Facts & Figures by Application
9 Latin America
9.1 Latin America Cholesterol Medicines by Country
9.1.1 Latin America Cholesterol Medicines Sales by Country
9.1.2 Latin America Cholesterol Medicines Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Cholesterol Medicines Market Facts & Figures by Type
9.3 Central & South America Cholesterol Medicines Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Cholesterol Medicines by Country
10.1.1 Middle East and Africa Cholesterol Medicines Sales by Country
10.1.2 Middle East and Africa Cholesterol Medicines Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Cholesterol Medicines Market Facts & Figures by Type
10.3 Middle East and Africa Cholesterol Medicines Market Facts & Figures by Application
11 Company Profiles
11.1 Pfizer Inc
11.1.1 Pfizer Inc Corporation Information
11.1.2 Pfizer Inc Description and Business Overview
11.1.3 Pfizer Inc Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Pfizer Inc Cholesterol Medicines Products Offered
11.1.5 Pfizer Inc Related Developments
11.2 Eli Lilly and Company
11.2.1 Eli Lilly and Company Corporation Information
11.2.2 Eli Lilly and Company Description and Business Overview
11.2.3 Eli Lilly and Company Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Eli Lilly and Company Cholesterol Medicines Products Offered
11.2.5 Eli Lilly and Company Related Developments
11.3 Abbott Laboratories
11.3.1 Abbott Laboratories Corporation Information
11.3.2 Abbott Laboratories Description and Business Overview
11.3.3 Abbott Laboratories Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Abbott Laboratories Cholesterol Medicines Products Offered
11.3.5 Abbott Laboratories Related Developments
11.4 Merck & Co
11.4.1 Merck & Co Corporation Information
11.4.2 Merck & Co Description and Business Overview
11.4.3 Merck & Co Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Merck & Co Cholesterol Medicines Products Offered
11.4.5 Merck & Co Related Developments
11.5 Bristol-Myers Squibb Company
11.5.1 Bristol-Myers Squibb Company Corporation Information
11.5.2 Bristol-Myers Squibb Company Description and Business Overview
11.5.3 Bristol-Myers Squibb Company Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Bristol-Myers Squibb Company Cholesterol Medicines Products Offered
11.5.5 Bristol-Myers Squibb Company Related Developments
11.6 AstraZeneca
11.6.1 AstraZeneca Corporation Information
11.6.2 AstraZeneca Description and Business Overview
11.6.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
11.6.4 AstraZeneca Cholesterol Medicines Products Offered
11.6.5 AstraZeneca Related Developments
11.7 Amgen Inc
11.7.1 Amgen Inc Corporation Information
11.7.2 Amgen Inc Description and Business Overview
11.7.3 Amgen Inc Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Amgen Inc Cholesterol Medicines Products Offered
11.7.5 Amgen Inc Related Developments
11.8 Novartis AG
11.8.1 Novartis AG Corporation Information
11.8.2 Novartis AG Description and Business Overview
11.8.3 Novartis AG Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Novartis AG Cholesterol Medicines Products Offered
11.8.5 Novartis AG Related Developments
11.9 GlaxoSmithKline
11.9.1 GlaxoSmithKline Corporation Information
11.9.2 GlaxoSmithKline Description and Business Overview
11.9.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
11.9.4 GlaxoSmithKline Cholesterol Medicines Products Offered
11.9.5 GlaxoSmithKline Related Developments
11.10 Regeneron Pharmaceuticals
11.10.1 Regeneron Pharmaceuticals Corporation Information
11.10.2 Regeneron Pharmaceuticals Description and Business Overview
11.10.3 Regeneron Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Regeneron Pharmaceuticals Cholesterol Medicines Products Offered
11.10.5 Regeneron Pharmaceuticals Related Developments
11.1 Pfizer Inc
11.1.1 Pfizer Inc Corporation Information
11.1.2 Pfizer Inc Description and Business Overview
11.1.3 Pfizer Inc Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Pfizer Inc Cholesterol Medicines Products Offered
11.1.5 Pfizer Inc Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Cholesterol Medicines Market Estimates and Projections by Region
12.1.1 Global Cholesterol Medicines Sales Forecast by Regions 2021-2026
12.1.2 Global Cholesterol Medicines Revenue Forecast by Regions 2021-2026
12.2 North America Cholesterol Medicines Market Size Forecast (2021-2026)
12.2.1 North America: Cholesterol Medicines Sales Forecast (2021-2026)
12.2.2 North America: Cholesterol Medicines Revenue Forecast (2021-2026)
12.2.3 North America: Cholesterol Medicines Market Size Forecast by Country (2021-2026)
12.3 Europe Cholesterol Medicines Market Size Forecast (2021-2026)
12.3.1 Europe: Cholesterol Medicines Sales Forecast (2021-2026)
12.3.2 Europe: Cholesterol Medicines Revenue Forecast (2021-2026)
12.3.3 Europe: Cholesterol Medicines Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Cholesterol Medicines Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Cholesterol Medicines Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Cholesterol Medicines Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Cholesterol Medicines Market Size Forecast by Region (2021-2026)
12.5 Latin America Cholesterol Medicines Market Size Forecast (2021-2026)
12.5.1 Latin America: Cholesterol Medicines Sales Forecast (2021-2026)
12.5.2 Latin America: Cholesterol Medicines Revenue Forecast (2021-2026)
12.5.3 Latin America: Cholesterol Medicines Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Cholesterol Medicines Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Cholesterol Medicines Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Cholesterol Medicines Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Cholesterol Medicines Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Cholesterol Medicines Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Cholesterol Medicines Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Cholesterol Medicines Market Segments
Table 2. Ranking of Global Top Cholesterol Medicines Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Cholesterol Medicines Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Oral
Table 5. Major Manufacturers of Injection
Table 6. Global Cholesterol Medicines Market Size Growth Rate by Application 2020-2026 (K Units)
Table 7. Global Cholesterol Medicines Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 8. Global Cholesterol Medicines Sales by Regions 2015-2020 (K Units)
Table 9. Global Cholesterol Medicines Sales Market Share by Regions (2015-2020)
Table 10. Global Cholesterol Medicines Revenue by Regions 2015-2020 (US$ Million)
Table 11. Global Cholesterol Medicines Sales by Manufacturers (2015-2020) (K Units)
Table 12. Global Cholesterol Medicines Sales Share by Manufacturers (2015-2020)
Table 13. Global Cholesterol Medicines Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 14. Global Cholesterol Medicines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cholesterol Medicines as of 2019)
Table 15. Cholesterol Medicines Revenue by Manufacturers (2015-2020) (US$ Million)
Table 16. Cholesterol Medicines Revenue Share by Manufacturers (2015-2020)
Table 17. Key Manufacturers Cholesterol Medicines Price (2015-2020) (USD/Unit)
Table 18. Cholesterol Medicines Manufacturers Manufacturing Base Distribution and Headquarters
Table 19. Manufacturers Cholesterol Medicines Product Type
Table 20. Date of International Manufacturers Enter into Cholesterol Medicines Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Global Cholesterol Medicines Sales by Type (2015-2020) (K Units)
Table 23. Global Cholesterol Medicines Sales Share by Type (2015-2020)
Table 24. Global Cholesterol Medicines Revenue by Type (2015-2020) (US$ Million)
Table 25. Global Cholesterol Medicines Revenue Share by Type (2015-2020)
Table 26. Cholesterol Medicines Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 27. Global Cholesterol Medicines Sales by Application (2015-2020) (K Units)
Table 28. Global Cholesterol Medicines Sales Share by Application (2015-2020)
Table 29. North America Cholesterol Medicines Sales by Country (2015-2020) (K Units)
Table 30. North America Cholesterol Medicines Sales Market Share by Country (2015-2020)
Table 31. North America Cholesterol Medicines Revenue by Country (2015-2020) (US$ Million)
Table 32. North America Cholesterol Medicines Revenue Market Share by Country (2015-2020)
Table 33. North America Cholesterol Medicines Sales by Type (2015-2020) (K Units)
Table 34. North America Cholesterol Medicines Sales Market Share by Type (2015-2020)
Table 35. North America Cholesterol Medicines Sales by Application (2015-2020) (K Units)
Table 36. North America Cholesterol Medicines Sales Market Share by Application (2015-2020)
Table 37. Europe Cholesterol Medicines Sales by Country (2015-2020) (K Units)
Table 38. Europe Cholesterol Medicines Sales Market Share by Country (2015-2020)
Table 39. Europe Cholesterol Medicines Revenue by Country (2015-2020) (US$ Million)
Table 40. Europe Cholesterol Medicines Revenue Market Share by Country (2015-2020)
Table 41. Europe Cholesterol Medicines Sales by Type (2015-2020) (K Units)
Table 42. Europe Cholesterol Medicines Sales Market Share by Type (2015-2020)
Table 43. Europe Cholesterol Medicines Sales by Application (2015-2020) (K Units)
Table 44. Europe Cholesterol Medicines Sales Market Share by Application (2015-2020)
Table 45. Asia Pacific Cholesterol Medicines Sales by Region (2015-2020) (K Units)
Table 46. Asia Pacific Cholesterol Medicines Sales Market Share by Region (2015-2020)
Table 47. Asia Pacific Cholesterol Medicines Revenue by Region (2015-2020) (US$ Million)
Table 48. Asia Pacific Cholesterol Medicines Revenue Market Share by Region (2015-2020)
Table 49. Asia Pacific Cholesterol Medicines Sales by Type (2015-2020) (K Units)
Table 50. Asia Pacific Cholesterol Medicines Sales Market Share by Type (2015-2020)
Table 51. Asia Pacific Cholesterol Medicines Sales by Application (2015-2020) (K Units)
Table 52. Asia Pacific Cholesterol Medicines Sales Market Share by Application (2015-2020)
Table 53. Latin America Cholesterol Medicines Sales by Country (2015-2020) (K Units)
Table 54. Latin America Cholesterol Medicines Sales Market Share by Country (2015-2020)
Table 55. Latin Americaa Cholesterol Medicines Revenue by Country (2015-2020) (US$ Million)
Table 56. Latin America Cholesterol Medicines Revenue Market Share by Country (2015-2020)
Table 57. Latin America Cholesterol Medicines Sales by Type (2015-2020) (K Units)
Table 58. Latin America Cholesterol Medicines Sales Market Share by Type (2015-2020)
Table 59. Latin America Cholesterol Medicines Sales by Application (2015-2020) (K Units)
Table 60. Latin America Cholesterol Medicines Sales Market Share by Application (2015-2020)
Table 61. Middle East and Africa Cholesterol Medicines Sales by Country (2015-2020) (K Units)
Table 62. Middle East and Africa Cholesterol Medicines Sales Market Share by Country (2015-2020)
Table 63. Middle East and Africa Cholesterol Medicines Revenue by Country (2015-2020) (US$ Million)
Table 64. Middle East and Africa Cholesterol Medicines Revenue Market Share by Country (2015-2020)
Table 65. Middle East and Africa Cholesterol Medicines Sales by Type (2015-2020) (K Units)
Table 66. Middle East and Africa Cholesterol Medicines Sales Market Share by Type (2015-2020)
Table 67. Middle East and Africa Cholesterol Medicines Sales by Application (2015-2020) (K Units)
Table 68. Middle East and Africa Cholesterol Medicines Sales Market Share by Application (2015-2020)
Table 69. Pfizer Inc Corporation Information
Table 70. Pfizer Inc Description and Major Businesses
Table 71. Pfizer Inc Cholesterol Medicines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 72. Pfizer Inc Product
Table 73. Pfizer Inc Recent Development
Table 74. Eli Lilly and Company Corporation Information
Table 75. Eli Lilly and Company Description and Major Businesses
Table 76. Eli Lilly and Company Cholesterol Medicines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 77. Eli Lilly and Company Product
Table 78. Eli Lilly and Company Recent Development
Table 79. Abbott Laboratories Corporation Information
Table 80. Abbott Laboratories Description and Major Businesses
Table 81. Abbott Laboratories Cholesterol Medicines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 82. Abbott Laboratories Product
Table 83. Abbott Laboratories Recent Development
Table 84. Merck & Co Corporation Information
Table 85. Merck & Co Description and Major Businesses
Table 86. Merck & Co Cholesterol Medicines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 87. Merck & Co Product
Table 88. Merck & Co Recent Development
Table 89. Bristol-Myers Squibb Company Corporation Information
Table 90. Bristol-Myers Squibb Company Description and Major Businesses
Table 91. Bristol-Myers Squibb Company Cholesterol Medicines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 92. Bristol-Myers Squibb Company Product
Table 93. Bristol-Myers Squibb Company Recent Development
Table 94. AstraZeneca Corporation Information
Table 95. AstraZeneca Description and Major Businesses
Table 96. AstraZeneca Cholesterol Medicines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 97. AstraZeneca Product
Table 98. AstraZeneca Recent Development
Table 99. Amgen Inc Corporation Information
Table 100. Amgen Inc Description and Major Businesses
Table 101. Amgen Inc Cholesterol Medicines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 102. Amgen Inc Product
Table 103. Amgen Inc Recent Development
Table 104. Novartis AG Corporation Information
Table 105. Novartis AG Description and Major Businesses
Table 106. Novartis AG Cholesterol Medicines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 107. Novartis AG Product
Table 108. Novartis AG Recent Development
Table 109. GlaxoSmithKline Corporation Information
Table 110. GlaxoSmithKline Description and Major Businesses
Table 111. GlaxoSmithKline Cholesterol Medicines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 112. GlaxoSmithKline Product
Table 113. GlaxoSmithKline Recent Development
Table 114. Regeneron Pharmaceuticals Corporation Information
Table 115. Regeneron Pharmaceuticals Description and Major Businesses
Table 116. Regeneron Pharmaceuticals Cholesterol Medicines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 117. Regeneron Pharmaceuticals Product
Table 118. Regeneron Pharmaceuticals Recent Development
Table 119. Global Cholesterol Medicines Sales Forecast by Regions (2021-2026) (K Units)
Table 120. Global Cholesterol Medicines Sales Market Share Forecast by Regions (2021-2026)
Table 121. Global Cholesterol Medicines Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 122. Global Cholesterol Medicines Revenue Market Share Forecast by Regions (2021-2026)
Table 123. North America: Cholesterol Medicines Sales Forecast by Country (2021-2026) (K Units)
Table 124. North America: Cholesterol Medicines Revenue Forecast by Country (2021-2026) (US$ Million)
Table 125. Europe: Cholesterol Medicines Sales Forecast by Country (2021-2026) (K Units)
Table 126. Europe: Cholesterol Medicines Revenue Forecast by Country (2021-2026) (US$ Million)
Table 127. Asia Pacific: Cholesterol Medicines Sales Forecast by Region (2021-2026) (K Units)
Table 128. Asia Pacific: Cholesterol Medicines Revenue Forecast by Region (2021-2026) (US$ Million)
Table 129. Latin America: Cholesterol Medicines Sales Forecast by Country (2021-2026) (K Units)
Table 130. Latin America: Cholesterol Medicines Revenue Forecast by Country (2021-2026) (US$ Million)
Table 131. Middle East and Africa: Cholesterol Medicines Sales Forecast by Country (2021-2026) (K Units)
Table 132. Middle East and Africa: Cholesterol Medicines Revenue Forecast by Country (2021-2026) (US$ Million)
Table 133. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 134. Key Challenges
Table 135. Market Risks
Table 136. Main Points Interviewed from Key Cholesterol Medicines Players
Table 137. Cholesterol Medicines Customers List
Table 138. Cholesterol Medicines Distributors List
Table 139. Research Programs/Design for This Report
Table 140. Key Data Information from Secondary Sources
Table 141. Key Data Information from Primary Sources
List of Figures
Figure 1. Cholesterol Medicines Product Picture
Figure 2. Global Cholesterol Medicines Sales Market Share by Type in 2020 & 2026
Figure 3. Oral Product Picture
Figure 4. Injection Product Picture
Figure 5. Global Cholesterol Medicines Sales Market Share by Application in 2020 & 2026
Figure 6. Cardiovascular Diseases
Figure 7. Liver Disease
Figure 8. Heart Disease
Figure 9. Others
Figure 10. Cholesterol Medicines Report Years Considered
Figure 11. Global Cholesterol Medicines Market Size 2015-2026 (US$ Million)
Figure 12. Global Cholesterol Medicines Sales 2015-2026 (K Units)
Figure 13. Global Cholesterol Medicines Market Size Market Share by Region: 2020 Versus 2026
Figure 14. Global Cholesterol Medicines Sales Market Share by Region (2015-2020)
Figure 15. Global Cholesterol Medicines Sales Market Share by Region in 2019
Figure 16. Global Cholesterol Medicines Revenue Market Share by Region (2015-2020)
Figure 17. Global Cholesterol Medicines Revenue Market Share by Region in 2019
Figure 18. Global Cholesterol Medicines Sales Share by Manufacturer in 2019
Figure 19. The Top 10 and 5 Players Market Share by Cholesterol Medicines Revenue in 2019
Figure 20. Cholesterol Medicines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 21. Global Cholesterol Medicines Sales Market Share by Type (2015-2020)
Figure 22. Global Cholesterol Medicines Sales Market Share by Type in 2019
Figure 23. Global Cholesterol Medicines Revenue Market Share by Type (2015-2020)
Figure 24. Global Cholesterol Medicines Revenue Market Share by Type in 2019
Figure 25. Global Cholesterol Medicines Market Share by Price Range (2015-2020)
Figure 26. Global Cholesterol Medicines Sales Market Share by Application (2015-2020)
Figure 27. Global Cholesterol Medicines Sales Market Share by Application in 2019
Figure 28. Global Cholesterol Medicines Revenue Market Share by Application (2015-2020)
Figure 29. Global Cholesterol Medicines Revenue Market Share by Application in 2019
Figure 30. North America Cholesterol Medicines Sales Growth Rate 2015-2020 (K Units)
Figure 31. North America Cholesterol Medicines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 32. North America Cholesterol Medicines Sales Market Share by Country in 2019
Figure 33. North America Cholesterol Medicines Revenue Market Share by Country in 2019
Figure 34. U.S. Cholesterol Medicines Sales Growth Rate (2015-2020) (K Units)
Figure 35. U.S. Cholesterol Medicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Canada Cholesterol Medicines Sales Growth Rate (2015-2020) (K Units)
Figure 37. Canada Cholesterol Medicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. North America Cholesterol Medicines Market Share by Type in 2019
Figure 39. North America Cholesterol Medicines Market Share by Application in 2019
Figure 40. Europe Cholesterol Medicines Sales Growth Rate 2015-2020 (K Units)
Figure 41. Europe Cholesterol Medicines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 42. Europe Cholesterol Medicines Sales Market Share by Country in 2019
Figure 43. Europe Cholesterol Medicines Revenue Market Share by Country in 2019
Figure 44. Germany Cholesterol Medicines Sales Growth Rate (2015-2020) (K Units)
Figure 45. Germany Cholesterol Medicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. France Cholesterol Medicines Sales Growth Rate (2015-2020) (K Units)
Figure 47. France Cholesterol Medicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. U.K. Cholesterol Medicines Sales Growth Rate (2015-2020) (K Units)
Figure 49. U.K. Cholesterol Medicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Italy Cholesterol Medicines Sales Growth Rate (2015-2020) (K Units)
Figure 51. Italy Cholesterol Medicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Russia Cholesterol Medicines Sales Growth Rate (2015-2020) (K Units)
Figure 53. Russia Cholesterol Medicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Europe Cholesterol Medicines Market Share by Type in 2019
Figure 55. Europe Cholesterol Medicines Market Share by Application in 2019
Figure 56. Asia Pacific Cholesterol Medicines Sales Growth Rate 2015-2020 (K Units)
Figure 57. Asia Pacific Cholesterol Medicines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 58. Asia Pacific Cholesterol Medicines Sales Market Share by Region in 2019
Figure 59. Asia Pacific Cholesterol Medicines Revenue Market Share by Region in 2019
Figure 60. China Cholesterol Medicines Sales Growth Rate (2015-2020) (K Units)
Figure 61. China Cholesterol Medicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Japan Cholesterol Medicines Sales Growth Rate (2015-2020) (K Units)
Figure 63. Japan Cholesterol Medicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. South Korea Cholesterol Medicines Sales Growth Rate (2015-2020) (K Units)
Figure 65. South Korea Cholesterol Medicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. India Cholesterol Medicines Sales Growth Rate (2015-2020) (K Units)
Figure 67. India Cholesterol Medicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Australia Cholesterol Medicines Sales Growth Rate (2015-2020) (K Units)
Figure 69. Australia Cholesterol Medicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Taiwan Cholesterol Medicines Sales Growth Rate (2015-2020) (K Units)
Figure 71. Taiwan Cholesterol Medicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Indonesia Cholesterol Medicines Sales Growth Rate (2015-2020) (K Units)
Figure 73. Indonesia Cholesterol Medicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Thailand Cholesterol Medicines Sales Growth Rate (2015-2020) (K Units)
Figure 75. Thailand Cholesterol Medicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Malaysia Cholesterol Medicines Sales Growth Rate (2015-2020) (K Units)
Figure 77. Malaysia Cholesterol Medicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Philippines Cholesterol Medicines Sales Growth Rate (2015-2020) (K Units)
Figure 79. Philippines Cholesterol Medicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Vietnam Cholesterol Medicines Sales Growth Rate (2015-2020) (K Units)
Figure 81. Vietnam Cholesterol Medicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Asia Pacific Cholesterol Medicines Market Share by Type in 2019
Figure 83. Asia Pacific Cholesterol Medicines Market Share by Application in 2019
Figure 84. Latin America Cholesterol Medicines Sales Growth Rate 2015-2020 (K Units)
Figure 85. Latin America Cholesterol Medicines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 86. Latin America Cholesterol Medicines Sales Market Share by Country in 2019
Figure 87. Latin America Cholesterol Medicines Revenue Market Share by Country in 2019
Figure 88. Mexico Cholesterol Medicines Sales Growth Rate (2015-2020) (K Units)
Figure 89. Mexico Cholesterol Medicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Brazil Cholesterol Medicines Sales Growth Rate (2015-2020) (K Units)
Figure 91. Brazil Cholesterol Medicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Argentina Cholesterol Medicines Sales Growth Rate (2015-2020) (K Units)
Figure 93. Argentina Cholesterol Medicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Latin America Cholesterol Medicines Market Share by Type in 2019
Figure 95. Latin America Cholesterol Medicines Market Share by Application in 2019
Figure 96. Middle East and Africa Cholesterol Medicines Sales Growth Rate 2015-2020 (K Units)
Figure 97. Middle East and Africa Cholesterol Medicines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 98. Middle East and Africa Cholesterol Medicines Sales Market Share by Country in 2019
Figure 99. Middle East and Africa Cholesterol Medicines Revenue Market Share by Country in 2019
Figure 100. Turkey Cholesterol Medicines Sales Growth Rate (2015-2020) (K Units)
Figure 101. Turkey Cholesterol Medicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. Saudi Arabia Cholesterol Medicines Sales Growth Rate (2015-2020) (K Units)
Figure 103. Saudi Arabia Cholesterol Medicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. U.A.E Cholesterol Medicines Sales Growth Rate (2015-2020) (K Units)
Figure 105. U.A.E Cholesterol Medicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Middle East and Africa Cholesterol Medicines Market Share by Type in 2019
Figure 107. Middle East and Africa Cholesterol Medicines Market Share by Application in 2019
Figure 108. North America Cholesterol Medicines Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 109. North America Cholesterol Medicines Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 110. Europe Cholesterol Medicines Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 111. Europe Cholesterol Medicines Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Asia Pacific Cholesterol Medicines Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 113. Asia Pacific Cholesterol Medicines Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Latin America Cholesterol Medicines Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 115. Latin America Cholesterol Medicines Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Middle East and Africa Cholesterol Medicines Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 117. Middle East and Africa Cholesterol Medicines Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Porter's Five Forces Analysis
Figure 119. Channels of Distribution
Figure 120. Distributors Profiles
Figure 121. Bottom-up and Top-down Approaches for This Report
Figure 122. Data Triangulation
Figure 123. Key Executives Interviewed
コレステロール低下生物学的薬剤の世界市場（～2026年） The cholesterol lowering biologic drugs offers a new, revolutionary alternative for people fighting with cholesterol with the same old treatments. The old method of treating cholesterol elevated levels includes a change in diet and consuming statin pills to prevent the body from making more bad chol…- コレステロール検査サービスの世界市場（～2026年） Market Analysis and Insights: Global Cholesterol Testing Services Market The global Cholesterol Testing Services market size is projected to reach US$ 12340 million by 2026, from US$ 11770 million in 2020, at a CAGR of 4.4%% during 2021-2026. Global Cholesterol Testing Services Scope and Market Size…
- コレステロール降下薬の世界市場（～2026年） Market Analysis and Insights: Global Cholesterol-Lowering Drugs Market The global Cholesterol-Lowering Drugs market size is projected to reach US$ 17960 million by 2026, from US$ 17440 million in 2020, at a CAGR of 2.8%% during 2021-2026. Global Cholesterol-Lowering Drugs Scope and Market Size Chole…
- 代替医療・治療法の世界市場（～2026年） Medicines which are used as an alternative or considered complementary medicinal treatment to a conventional medical treatment are known as alternative medicines. It is a natural method of treatment which excludes usual methodology of allopathy. This type of treatment is not a part of the study prog…
- 非アルコール性脂肪肝疾患治療薬の世界市場（～2026年） Nonalcoholic fatty liver disease (NAFLD) is a condition in which excessive fatty accumulation in the hepatocytes. There are two types of NAFLD, namely simple fatty liver and non-alcoholic steatohepatitis. In simple fatty liver, the fat in the liver is very less and there is no inflammation or liver …